Bioactive compounds
Traditionally the main function of food is to provide us with nutrition such as carbohydrates, lipids and proteins. In addition to its nutrition values, food also contains bioactive compounds which modulate human physiology. Food rich in bioactive compounds can even contribute to preventing lifestyle-related diseases. Plants produce secondary metabolites which can be used as bioactive compounds in human beings (Crozier et al., 2006) . Soybean produces nicotianamine as a secondary metabolite, and it functions as a transporter of metals in plants (Aoyagi, 2006) . That works as angiotensionconverting enzyme (ACE) inhibitor in human being, lowering blood pressure (Aoyagi, 2006) . Plant chemicals can be divided into primary and secondary nutrients (Crozier et al., 2006) . The primary nutrients are used for the growth and reproduction of the plants, and the secondary are used for their defense in the adverse environments including desiccation (Marriott, 2000) . Also, plants have many bioactive compounds including antioxidants to prevent them from toxic UV. The secondary ones are also called allelochemicals and those numbers reach 12,455 (Marriott, 2000) . These allelochemicals function as bioactive compounds in human being by affecting human physiology.
Also, modern people eat much of refined food which is short in vitamin, mineral and dietary fiber. The imbalances of these nutrients are involved in diabetes, obesity, etc. Thus, eating nutritional supplements is helpful for preventing them.
The Korean HFF act
Health supplement food (HSF) had not been well distinguished from conventional food in Korea. Both HSF and conventional food had been regulated under the food hygiene act. Most of previous HSF has been absorbed into new Health Functional Food (HFF). HFF has been strictly distinguished from medicine. Medicine is regulated by the pharmaceutical affairs act, and HFF by the HFF act separately. If medicinal benefit overrides its side effects, that medicine can be allowed. However, HFF having any toxicity or harm is not allowed, although it has some benefits. Medicine can claim medicinal effects to prevent or cure a specific disease. HFF can claim functionality but not the medicinal effects. Conventional food can not claim any functionality presently.
Previous HSF was approved by just reporting to a rural administrative office, without any evaluation based on scientific data. HSF had 24 categories. They could produce only items belonging to the categories of HSF. It was extremely difficult to introduce new ingredients which do not belong to the 24 categories. However, new HFF act has allowed new ingredients to be introduced as HFF, following proper evaluations by Korea Food and Drug Administration (KFDA). Also improper labeling and false advertisement of HSF had not been rare, and amount to take had not been shown in many cases. The new HFF act corrected these negative aspects.
The Korean HFF act is expected to promote health of the people and protect the consumer by regulating the labeling and advertisement. The new act makes it easy for new ingredients in HFF to be introduced. Also accurate information about HFF on the labeling helps the people to make right choices in buying it. The HFF act has been launched on since Jan 13, 2004 (Ministry of Health and Welfare, Korea, 2004) . Since then, several revisions have been made. HFF had been previously defined as a manufactured and processed food having the forms of capsule, tablet, powder, soft gel, gel-cap, and liquid, with bioactive ingredients. There have been many opinions that the form restriction inhibits new development of resources based on modern techniques. New revision of the HFF act has been made, and the restriction on its forms has been abandoned. Bioactivity should result in usefulness by controlling nutrients which constitute human body or by affecting human physiology. The functional ingredients of HFF should contribute to the maintenance or improvement of human health. In the act, HFF is regarded as food supplements of the normal diet.
General standard HFF
KFDA manages its dual registration system for HFF. One is general standard HFF and the other is HFF recognized individually. KFDA had recognized previously 37 standard HFFs including soybean protein, etc. KFDA guarantees their safety and effectiveness. Any HFF which satisfies the general standard and specification can be approved without submitting scientific evidence. General standard HFF is divided into nutrients and functional ingredients (KFDA, 2008) (Table 1) . Nutrients are subdivided into vitamins and minerals, dietary fibers, proteins, and essential fatty acids. Functional ingredients are subdivided into terpenes, phenols, fatty acids, sugars and carbohydrates, fermentative microbe, amino acids and proteins, and general ingredients. Each category is divided again into final ingredients. For example, sugars and carbohydrates contain glucosamine, N-acetyl glucosamine, muco polysaccharide-protein, dietary fibers, aloe gel, yongji-mushroom fruit-body extracts, chitosan/chito-oligosaccharide, and fructo-oligosaccharide.
Evaluation process of HFF recognized individually
If a company makes HFF which is not in the list of the standard categories and has a new ingredient, the company should obtain KFDA recognition individually, after submitting its scientific evidence data and passing evaluation tests.
Overall needed. The analysis method for the validation of index (biomarker) should be established. A content change of index components during the processing is also checked. Using medicinal resources for HFF is strictly forbidden. Resources for medicinal use such as adonis, codeine, calcitonin (84 items) should not be used, as the ingredients of HFF. KFDA checks the origin and nature of the active components, the contents of index components, processing methods, solvents used for the extraction in the process of safety evaluation. Toxic materials such as microorganisms, heavy metal, chemicals should not exist in the sample. Any side effects and toxicity of an ingredient are checked, using database searches and examining the toxicity tests submitted. Synthesized ingredient that is approved by KFDA can be used. To prove functionality, KFDA evaluates in vitro experiment, animal and human studies, epidemiology survey, articles submitted by the company. Human study is preferred and most convincing. If only animal and in vitro studies are submitted without human study, it could receive other function (III) level. KFDA determines quality of scientific data submitted by evidence-based evaluation. Kinds and types of evidence for substantiating a claim are not formulated. Any kinds of reliable scientific data are acceptable. Data quality is determined by checking factors such as study design, subjects, materials, methods, objectives, biomarkers, statistics, and confounding factor. KFDA rates HFF based on levels of scientific evidence. Depending on 4 levels of scientific evidence, 4 types of claims are determined. 'Reduction of disease risk' is given to strong scientific evidence, 'other function (I)' to convincing evidence, 'other function (II)' to probable evidence, and 'other function (III)' to insufficient evidence. To obtain the claim of 'reduction of disease risk' is most difficult and the product belonging to the claim is hardly found. Most of HFF products belong to other function (II) or (III). Also the products belonging to other function (I) are relatively rare.
Once safety and efficacy of a functional ingredient is recognized, KFDA issues the certificate for the ingredient. Using that, specification of the final product is submitted again and approved. HFF recognized individually in the category of other function can claim 'reduction of blood pressure or glucose level' statement. Various statements are shown in Table 2 . As of June 16, 2008, recognition of functional ingredients has reached 66, and that of final products based on functional ingredients has totaled 152.
Labeling and selling
Nutritional and functional information should be demonstrated on the label. Nutrition-function claim, other-function claim, and reduction-of-disease-risk claim can be demonstrated on the label. Nutrition-function claim demonstrates physiological role of nutrients, and other-function claim describes specific biological effects on function improvement or health maintenance. Reduction-of-disease-risk claim deals with reduction of disease-risk by consuming HFF in addition to the normal diet.
It is compulsory to demonstrate 'health functional food' or HFF mark (Fig. 1) approved by KFDA, dose, intake method, its period of circulation, and a keeping method on the label of each HFF. It should be demonstrated on the product that it is not a medicine for curing a disease. In the advertisement, HFF should not be confused into any medicine. False and exaggerative advertisements should be avoided. Prior deliberation for its advertisement by a relevant committee is needed. Good manufacturing practice (GMP) is given to the company producing quality products in addition to its HFF recognition. All processes of manufacture, working place structure, packing and shipping are checked systemically. The GMP mark guarantees its quality. Consumers can trust HFF having GMP mark more than any other products. The companies expect the HFF export having GMP mark to increase more. Cases of law violation include addition of drug material such as sildenafil which is for sexual function improvement, and glibenclamide for blood sugar reduction. Illegitimate circulaHealth Functional Food in Korea   Fig. 1 . HFF mark. tion without import declaration is reported. Excess and false advertisements are also one of law violations.
HFF industry
Food and pharmaceutical companies produce many kinds of HFF. In early 1980's, squalene dominated the market, in 1990's chitosan dominated. In 2000's, chlorella and glucosamine for woman were popular. KFDA reported that total sales of HFF in 2007 reached 723.4 billion Won. Red ginseng; 327, Aloe; 79.7, nutrition supplements; 78.5, ginseng; 35, glucosamine; 27 billion Won, respectively (Fig. 2) . Red ginseng occupied 45.2% of total market (Fig. 2) . Compared to the selling amount in 2006, red ginseng increased by 32%. Red ginseng (steamed ginseng) is registered for its anti-fatigue, immune improvement, and blood-circulation improvement effects. However, selling of chlorella, glucosamine decreased by more than 40%, compared to that in 2006. These reflect each product's effectiveness among the public. In the beginning the public are influenced much by the advertisements. Once they take and find them ineffective, then they stop buying them.
To develop HFFs recognized individually, enormous fund for its research and development, and clinical experiments is needed. Big companies increase their investments, because they want to have competitiveness. Among HFFs recognized individually, conjugated linoleic acid and coenzyme Q10 begin to have popularity. Recently prostate care product, nondigestible maltodextrin (control of blood sugar) are shown on the market. These days apart from HFFs for preventing lifestyle related disease, HFF for preventing obesity, skin care are also popular items. According to KFDA statistics, imported HFF from foreign countries reached 200.4 billon Won in 2007. Korean HFF market sizes were estimated to be 1.8, 2.1, 2.3 trillion Won in 2004, 2005, and 2006 , respectively. Business people expect that it will grow more, reaching 4 trillion Won in 2010. To develop and sell HFF, enormous money is needed. Small companies do not have the capacity to invest. Thus, big companies begin to dominate Korean HFF market. Big companies have a tendency to develop HFF recognized individually rather than general and standard HFF. Also diverse and specified products will emerge on the market.
Integrative approach using not only food science but also molecular biology, nutrigenomics will make us understand how food ingredients affect human physiology at molecular levels more clearly. Ultimately, that approach will lead to development of superior HFF. 
